12/24
08:13 am
maia
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings [Yahoo! Finance]
Medium
Report
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings [Yahoo! Finance]
12/24
08:01 am
maia
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings
Medium
Report
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings
12/16
04:15 pm
maia
MAIA Biotechnology Announces $1.51 Million Private Placement
Medium
Report
MAIA Biotechnology Announces $1.51 Million Private Placement
12/11
01:45 pm
maia
MAIA's Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates [Yahoo! Finance]
Medium
Report
MAIA's Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates [Yahoo! Finance]
12/11
01:00 pm
maia
MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates
Medium
Report
MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates
12/11
09:14 am
maia
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer [Yahoo! Finance]
High
Report
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer [Yahoo! Finance]
12/11
09:00 am
maia
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer
High
Report
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer
12/11
08:27 am
maia
MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential [Yahoo! Finance]
High
Report
MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential [Yahoo! Finance]
12/11
08:00 am
maia
MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential
High
Report
MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential
12/10
02:42 pm
maia
MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach [Yahoo! Finance]
Low
Report
MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach [Yahoo! Finance]
12/10
02:00 pm
maia
MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach
Low
Report
MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach
12/1
09:36 am
maia
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors [Yahoo! Finance]
Medium
Report
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors [Yahoo! Finance]
12/1
09:17 am
maia
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors
Medium
Report
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors
11/21
09:01 am
maia
MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025
Low
Report
MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025
11/20
09:22 am
maia
MAIA Biotechnology CEO Presents Telomere Targeting Efficacy at Romania's 2025 Smart Diaspora Conference on Oncology Research and Innovation [Yahoo! Finance]
Medium
Report
MAIA Biotechnology CEO Presents Telomere Targeting Efficacy at Romania's 2025 Smart Diaspora Conference on Oncology Research and Innovation [Yahoo! Finance]
11/20
08:47 am
maia
MAIA Biotechnology CEO Presents Telomere Targeting Efficacy at Romania’s 2025 Smart Diaspora Conference on Oncology Research and Innovation
Medium
Report
MAIA Biotechnology CEO Presents Telomere Targeting Efficacy at Romania’s 2025 Smart Diaspora Conference on Oncology Research and Innovation
11/10
08:18 am
maia
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) [Yahoo! Finance]
Low
Report
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) [Yahoo! Finance]
10/27
10:45 am
maia
MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Low
Report
MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
10/23
08:36 am
maia
MAIA Biotechnology Details 30-Month Patient Survival in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
Low
Report
MAIA Biotechnology Details 30-Month Patient Survival in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
10/13
04:20 pm
maia
MAIA Biotechnology Announces $736,600 Private Placement
Medium
Report
MAIA Biotechnology Announces $736,600 Private Placement
10/7
03:33 pm
maia
Cancer drug maker takes sudden pivot into crypto [Yahoo! Finance]
Low
Report
Cancer drug maker takes sudden pivot into crypto [Yahoo! Finance]
10/7
09:13 am
maia
MAIA Biotechnology to hold up to 90% of liquid assets in crypto [Seeking Alpha]
Medium
Report
MAIA Biotechnology to hold up to 90% of liquid assets in crypto [Seeking Alpha]
10/7
08:47 am
maia
MAIA Biotechnology to Initiate Digital Asset Treasury Strategy Focused on Top-Tier Crypto Assets
Medium
Report
MAIA Biotechnology to Initiate Digital Asset Treasury Strategy Focused on Top-Tier Crypto Assets
9/29
04:30 pm
maia
MAIA Biotechnology Announces $2.25 Million Private Placement
Low
Report
MAIA Biotechnology Announces $2.25 Million Private Placement